Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride in combination with at least one glucocorticoid corticosteroid for use in the treatment of muscular dystrophy
RS68069B1Active Publication Date: 2026-05-29ITALFARMACO SPA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- RS68069P0
- Authority / Receiving Office
- RS · RS
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2012-02-03
- Filing Date
- 2012-02-03
- Publication Date
- 2026-05-29
- Estimated Expiration
- 2032-02-03
Need to check novelty before this filing date? Find Prior Art
No text content released.